Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Search Product Recalls

Try:····

Filters

Category

All Categories Food Medication Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Severity

All Severities Class I (High Risk)Class II (Moderate)Class III (Low)

Source

All Sources FDA CPSC USDA NHTSA

Status

Include terminated recalls

Clear all filters

Showing 8681–8700 of 15081 results

Sort:

Newest first Oldest first

M.L.C./B5/B6 Injectable (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

17-OH Progesterone Injectable (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

M.L.C. Injectable (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Gentamicin Ophthalmic Solution (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Itraconazole/Mupirocin Nasal Spray (Well Care Compounding) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Quad-Mix #2 (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Super Tri-Mix #1 (Well Care Compounding) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Myers' Cocktail (Well Care Compounding) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

HCG Injectable (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Estradiol Valerate 40mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Quad-Mix #4 Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Tri-Mix #2 Injectable (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Estradiol Valerate 10mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Testosterone Cypionate 100mg/ml Vials (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Atropine Sulfate Drops (Well Care Compounding) – Sterility Concern (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Tri-Mix #6 (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Tri-Mix #4 (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Super Tri-Mix #4 (Well Care) – Sterility Concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

MB 12/HXB 12 Mix (Well Care) – sterility concerns (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

Testosterone Cypionate (Well Care Compounding) – Sterility Concern (2016)

Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.

Class IIModerate

FDAMay 17, 2016NV• Well Care Compounding Pharmacy

1...433 434435436 437...755

Page 435 of 755Next